[Considerations on HL-A antigens and their isolation].
D000741:Anemia, Aplastic / Q000276:immunology; D000818:Animals; D001963:Bromelains / Q000494:pharmacology; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D005188:False Negative Reactions; D005260:Female; D005557:Formaldehyde / Q000494:pharmacology; D006649:Histocompatibility Antigens / Q000302:isolation & purification*; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007938:Leukemia / Q000276:immunology; D008206:Lymphatic Diseases / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008233:Lymphotoxin-alpha / Q000032:analysis; D008297:Male; D009380:Neoplasms, Nerve Tissue / Q000276:immunology; D055728:Primary Myelofibrosis / Q000276:immunology; D011817:Rabbits / Q000276:immunology
D006649:Histocompatibility Antigens; D008233:Lymphotoxin-alpha; D005557:Formaldehyde; D001963:Bromelains; D003165:Complement System Proteins
Einige Bemerkungen zu den HL-A-Antigenen und ihrer Bestimmung